- Home
- ATNF vs PALI Comparison
ATNF vs PALI Comparison
Compare ATNF & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- PALI
- Stock Information
- Founded
- ATNF 2016
- PALI 1996
- Country
- ATNF United States
- PALI United States
- Employees
- ATNF N/A
- PALI N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- PALI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATNF Health Care
- PALI Health Care
- Exchange
- ATNF Nasdaq
- PALI Nasdaq
- Market Cap
- ATNF 3.8M
- PALI 3.2M
- IPO Year
- ATNF N/A
- PALI N/A
- Fundamental
- Price
- ATNF $1.05
- PALI $0.70
- Analyst Decision
- ATNF
- PALI Strong Buy
- Analyst Count
- ATNF 0
- PALI 2
- Target Price
- ATNF N/A
- PALI $12.00
- AVG Volume (30 Days)
- ATNF 43.3K
- PALI 410.9K
- Earning Date
- ATNF 05-15-2025
- PALI 05-12-2025
- Dividend Yield
- ATNF N/A
- PALI N/A
- EPS Growth
- ATNF N/A
- PALI N/A
- EPS
- ATNF N/A
- PALI N/A
- Revenue
- ATNF N/A
- PALI N/A
- Revenue This Year
- ATNF N/A
- PALI N/A
- Revenue Next Year
- ATNF N/A
- PALI N/A
- P/E Ratio
- ATNF N/A
- PALI N/A
- Revenue Growth
- ATNF N/A
- PALI N/A
- 52 Week Low
- ATNF $0.66
- PALI $0.60
- 52 Week High
- ATNF $17.75
- PALI $5.15
- Technical
- Relative Strength Index (RSI)
- ATNF 49.77
- PALI 44.12
- Support Level
- ATNF $1.01
- PALI $0.67
- Resistance Level
- ATNF $1.10
- PALI $0.86
- Average True Range (ATR)
- ATNF 0.08
- PALI 0.06
- MACD
- ATNF -0.01
- PALI -0.01
- Stochastic Oscillator
- ATNF 35.29
- PALI 22.24
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.